Form 8-K - Current report:
SEC Accession No. 0001564590-21-003032
Filing Date
2021-01-28
Accepted
2021-01-28 16:16:50
Documents
3
Period of Report
2021-01-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_EGM RESULTS itrm-8k_20210122.htm 8-K 55048
2 EX-3.1 itrm-ex31_7.htm EX-3.1 877196
3 EX-99.1 itrm-ex991_6.htm EX-99.1 12125
  Complete submission text file 0001564590-21-003032.txt   945833
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 21565157
SIC: 2834 Pharmaceutical Preparations